ECM
DXCM icon

ExodusPoint Capital Management’s DexCom DXCM Stock Holding History

ExodusPoint Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.9M Buy
317,067
+183,013
+137% +$12.7M 0.16% 104
2025
Q4 		$8.9M Buy
134,054
+98,240
+274% +$6.35M 0.07% 287
2025
Q3 		$2.41M Sell
35,814
-630,312
-95% -$49.9M 0.02% 675
2025
Q2 		$58.1M Buy
+666,126
New +$52.2M 0.51% 28
2025
Q1 		– Sell
-466,414
Closed -$36.3M – 1591
2024
Q4 		$36.3M Buy
466,414
+309,714
+198% +$22.9M 0.25% 60
2024
Q3 		$10.5M Buy
156,700
+104,667
+201% +$8.6M 0.06% 226
2024
Q2 		$5.9M Sell
52,033
-106,895
-67% -$13.5M 0.04% 360
2024
Q1 		$22M Buy
158,928
+150,277
+1,737% +$18.9M 0.17% 93
2023
Q4 		$1.07M Sell
8,651
-66,268
-88% -$6.77M 0.01% 797
2023
Q3 		$6.99M Buy
+74,919
New +$8.45M 0.07% 300
2023
Q2 		– Sell
-54,880
Closed -$6.38M – 1941
2023
Q1 		$6.38M Sell
54,880
-18,034
-25% -$2.02M 0.05% 428
2022
Q4 		$8.26M Buy
72,914
+67,747
+1,311% +$7.44M 0.12% 219
2022
Q3 		$416K Sell
5,167
-126,785
-96% -$10.7M 0.01% 1431
2022
Q2 		$9.83M Buy
131,952
+100,424
+319% +$9.17M 0.12% 197
2022
Q1 		$4.03M Sell
31,528
-20,408
-39% -$2.23M 0.05% 463
2021
Q4 		$6.97M Buy
51,936
+8,112
+19% +$1.17M 0.07% 323
2021
Q3 		$5.99M Buy
43,824
+28,068
+178% +$3.54M 0.08% 335
2021
Q2 		$1.68M Buy
+15,756
New +$1.51M 0.02% 763
2020
Q4 		– Sell
-1,460
Closed -$150K – 2049
2020
Q3 		$150K Sell
1,460
-31,132
-96% -$3.25M ﹤0.01% 1545
2020
Q2 		$3.3M Sell
32,592
-2,588
-7% -$232K 0.09% 261
2020
Q1 		$2.37M Sell
35,180
-9,856
-22% -$613K 0.13% 159
2019
Q4 		$2.46M Sell
45,036
-76,488
-63% -$3.63M 0.05% 292
2019
Q3 		$4.53M Buy
121,524
+110,040
+958% +$4.28M 0.16% 125
2019
Q2 		$430K Sell
11,484
-12,736
-53% -$400K 0.02% 534
2019
Q1 		$721K Buy
+24,220
New +$851K 0.05% 245

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ExodusPoint Capital Management's DXCM Position: Q1 2026 in Review

ExodusPoint Capital Management increased its DexCom (DXCM) stake by 137% in Q1 2026, buying an estimated $12.7M and bringing the position to 317,067 shares worth $19.9M. The position accounts for 0.16% of the portfolio, ranked #104.

ExodusPoint Capital Management first reported a position in DXCM in Q1 2019 and has held it in 25 quarters since. The position peaked at $58.1M in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • ExodusPoint Capital Management held 317,067 shares of DexCom worth $19.9M as of Q1 2026.
  • ExodusPoint Capital Management bought 183,013 DexCom shares in Q1 2026, an estimated $12.7M.
  • DexCom made up 0.16% of ExodusPoint Capital Management's portfolio in Q1 2026, its #104 holding.
  • ExodusPoint Capital Management first reported a position in DexCom in Q1 2019 and has held it in 25 quarters since.
  • ExodusPoint Capital Management's DexCom position peaked at $58.1M in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.